Transaction · 0001971798-26-000005

Wambeke David J.

Wambeke David J., CBO, reported a transaction classified as grant at NEUROONE MEDICAL TECHNOLOGIES Corp involving 35000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 35000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACBO
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Trade date
Aug 28, 2026
Filing date
Sep 08, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded35.0k$0.00 per share
Holdings after35.0kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 11 calendar days after the transaction date.

NMTC price since this filing

Daily closing prices, with the filing date and available return windows
NMTC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.4%1w ago +19.5%1d ago +24.9%
Returns since7d -13.6%30d -34.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001971798-26-000005
Option to Purchase Common Stock
Transaction date
Aug 28, 2026
Filed Sep 08, 2026, 12:31 PM · 11d delay
Shares
35,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
35,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • delayed_filing-6 points

    reporting_delay_days = 11

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $2.00 and $2.017 per share. Upon request by the SEC staf…

  2. F2

    25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Original filing · 0001971798-26-000005
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

NMTC